Home › Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology
 

Keywords :   


Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology

2015-11-16 19:03:27| Biotech - Topix.net

After discussing Celsion Corporation in my first Stories To Watch Into SABCS, I will discuss upcoming data at SABCS for Oncothyreon and Puma Biotechnology in my second piece. I believe either notable ORR improvement for the ONT-380/T DM1 trial or continued display of promising efficacy trends in the brain metastases patient group could trigger a $5+pps for ONTY.

Tags: track stories weekly biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »